2023/10/24 更新

写真a

ミナガワ　ユキ
皆川　友希
Minagawa Yuki
所属
武蔵小杉病院 女性診療科・産科 助教
職名
助教
外部リンク

論文

  • High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma. 国際誌

    Yuki Minagawa, Kousuke Ishino, Ryuichi Wada, Mitsuhiro Kudo, Zenya Naito, Toshiyuki Takeshita, Ryuji Ohashi

    Anticancer research   40 ( 10 )   5631 - 5639   2020年10月

    　詳細を見る

    記述言語：英語   掲載種別：研究論文（学術雑誌）  

    BACKGROUND/AIM: DNA damage response (DDR), wherein p21 is a cell fate determinant, is a potential cancer therapeutic target. Molecular expression during DDR was explored in ovarian clear-cell carcinoma (CCC). MATERIALS AND METHODS: CHK1, CHK2, TP53 and p21 expression in DDR was examined using immunostaining in surgical sections of CCC (n=22). Molecular alterations in two types of CCC cell lines, JHOC-5 and JHOC-9, were investigated using western blot analysis. RESULTS: Expression of DDR-associated molecules was noted in most patients. While high p21 expression was found in half of the patients, the remaining patients exhibited low p21 expression. Treatment with UC2288, a p21 inhibitor, attenuated proliferation of both cell lines, more prominently in JHOC-9, resulting in reduced viability and subsequent apoptosis. CONCLUSION: p21 Inhibitor induced cell death in cells with high p21 expression, suggesting that p21 suppression can be a therapeutic strategy to treat patients with CCC.

    DOI： 10.21873/anticanres.14576

    PubMed

    researchmap

MISC